Adrenomedullin signaling is necessary for murine lymphatic vascular development
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
The lymphatic vascular system mediates fluid homeostasis, immune defense, and tumor metastasis. Only a handful of genes are known to affect the development of the lymphatic vasculature, and even fewer represent therapeutic targets for lymphatic diseases. Adrenomedullin (AM) is a multifunctional peptide vasodilator that transduces its effects through the calcitonin receptor-like receptor (calcrl) when the receptor is associated with a receptor activity-modifying protein (RAMP2). Here we report on the involvement of these genes in lymphangiogenesis. AM-, calcrl-, or RAMP2-null mice died mid-gestation after development of interstitial lymphedema. This conserved phenotype provided in vivo evidence that these components were required for AM signaling during embryogenesis. A conditional knockout line with loss of calcrl in endothelial cells confirmed an essential role for AM signaling in vascular development. Loss of AM signaling resulted in abnormal jugular lymphatic vessels due to reduction in lymphatic endothelial cell proliferation. Furthermore, AM caused enhanced activation of ERK signaling in human lymphatic versus blood endothelial cells, likely due to induction of CALCRL gene expression by the lymphatic transcriptional regulator Prox1. Collectively, our studies identify a class of genes involved in lymphangiogenesis that represent a pharmacologically tractable system for the treatment of lymphedema or inhibition of tumor metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetic deficiency in either adrenomedullin, Calcrl, or Ramp2 (27,57,74) is embryonic lethal at midgestation because of cardiovascular defects and a hypoproliferative lymphatic vasculature, whereas Ramp1 KO and Ramp3 KO are viable (57,131,203).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [74]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Calcrl Calcitonin receptor-like receptor (CRLR) Embryonic lethal (57, 74)”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Ramp2 RAMP2 Embryonic lethal (74)”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 1×
“The ligand-binding affinity of CLR (and other class II GPCRs) can be changed via receptor interaction with a class of single-pass transmembrane proteins called receptor activity–modifying proteins (RAMPs) (29).”
BackgroundInduction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Prox1 Function Is Required for the Development of the Murine Lymphatic System
Wigle, J. T., & Oliver, G. (1999) · Cell · doi:10.1016/s0092-8674(00)81511-1 · Cited by 1,579 · cited 5×
“Therefore, we transfected a hProx1 expression plasmid into cultured HMVEC-dLys and measured mRNA production of endogenous LYVE and CALCRL.”
BackgroundResultInfluentialKarkkainen, M. J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T. V., Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H., et al. (2004) · Nature Immunology · doi:10.1038/ni1013 · Cited by 1,421 · cited 3×
“Thus, based on the absence of blood hemorrhage, the presence of embryonic lymphedema, and the fact that the edematous phenotype of AM signaling–null mice more closely resembled that of other mouse models with defects in lymphangiogenesis (10, 11, 14) rather than defects in blood vascular permeability (40–43), we hypot…”
BackgroundLymphangiogenesis in development and human disease
Alitalo, K., Tammela, T., & Petrova, T. V. (2005) · Nature · doi:10.1038/nature04480 · Cited by 1,285 · cited 2×
“While a few of these gene products, such as VEGFC and angiopoietins, show promise as potential targets for the stimulation, inhibition, or modulation of lymphangiogenesis and lymphatic function in lymphedematous tissues or tumors of adult animals (17), there remains a crucial need to identify additional genetic and ph…”
BackgroundOptical Projection Tomography as a Tool for 3D Microscopy and Gene Expression Studies
Sharpe, J., Ahlgren, U., Perry, P., Hill, B., Ross, A., Hecksher-Sørensen, J., Baldock, R., & Davidson, D. (2002) · Science · doi:10.1126/science.1068206 · Cited by 1,158
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
Wigle, J. T., Harvey, N., Detmar, M., Lagutina, I., Grosveld, G., Gunn, M. D., Jackson, D. G., & Oliver, G. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1505 · Cited by 943 · cited 2×
“Prox1 is expressed in a polarized fashion in the venous endothelium and serves as a master switch for establishing LEC competence (9).”
BackgroundT1 /podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema
Schacht, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg342 · Cited by 653 · cited 1×
“Finally, several genes have been implicated in the later stages of lymphatic vessel patterning and postnatal maturation, including podoplanin (13), neuropillin2 (14), FoxC2 (15), and angiopoietin-2 (16).”
BackgroundPetrova, T. V., Mäkinen, T., Mäkelä, T. P., Saarela, J., Virtanen, I., Ferrell, R. E., Finegold, D. N., Kerjaschki, D., Ylä‐Herttuala, S., & Alitalo, K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf470 · Cited by 632 · cited 1×
“Several comparative transcriptional profiling studies have shown enhanced expression of AM signaling genes in lymphatic versus blood endothelial cells (46, 47) and lymphedematous versus normal vasculature (48).”
BackgroundAbnormal lymphatic vessel development in neuropilin 2 mutant mice
Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., & Eichmann, A. (2002) · Development · doi:10.1242/dev.129.20.4797 · Cited by 632
Petrova, T. V., Karpanen, T., Norrmén, C., Mellor, R., Tamakoshi, T., Finegold, D., Ferrell, R., Kerjaschki, D., Mortimer, P., Ylä-Herttuala, S., et al. (2004) · Nature Medicine · doi:10.1038/nm1094 · Cited by 592 · cited 1×
“Finally, several genes have been implicated in the later stages of lymphatic vessel patterning and postnatal maturation, including podoplanin (13), neuropillin2 (14), FoxC2 (15), and angiopoietin-2 (16).”
BackgroundNakagami, H., Maeda, K., Morishita, R., Iguchi, S., Nishikawa, T., Takami, Y., Kikuchi, Y., Saito, Y., Tamai, K., Ogihara, T., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000190701.92007.6d · Cited by 577
Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice
Koni, P. A., Joshi, S. K., Temann, U.-A., Olson, D., Burkly, L., & Flavell, R. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.741 · Cited by 482 · cited 2×
“We noticed a slight reduction in the Mendelian distribution of calcrlFloxP/–Tie2Cre– mice (Figure 2F), which is consistent with the leakiness of the Tie2Cre transgene in the female germline leading to global calcrl excision and embryonic lethality (37).”
MethodResultPharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
Doods, H., Hallermayer, G., Wu, D., Entzeroth, M., Rudolf, K., Engel, W., & Eberlein, W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703110 · Cited by 466 · cited 3×
“Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.”
BackgroundHirakawa, S., Hong, Y.-K., Harvey, N., Schacht, V., Matsuda, K., Libermann, T., & Detmar, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63851-5 · Cited by 439 · cited 1×
“Several comparative transcriptional profiling studies have shown enhanced expression of AM signaling genes in lymphatic versus blood endothelial cells (46, 47) and lymphedematous versus normal vasculature (48).”
BackgroundRegulation of Blood and Lymphatic Vascular Separation by Signaling Proteins SLP-76 and Syk
Abtahian, F., Guerriero, A., Sebzda, E., Lu, M.-M., Zhou, R., Mocsai, A., Myers, E. E., Huang, B., Jackson, D. G., Ferrari, V. A., et al. (2003) · Science · doi:10.1126/science.1079477 · Cited by 421 · cited 1×
“Mice with homozygous deletions for the genes encoding these proteins develop arteriovenous shunts and abnormal lymphatic-venous connections (12).”
BackgroundGene transfer as a tool to induce therapeutic vascular growth
Ylä-Herttuala, S., & Alitalo, K. (2003) · Nature Medicine · doi:10.1038/nm0603-694 · Cited by 404 · cited 1×
“While a few of these gene products, such as VEGFC and angiopoietins, show promise as potential targets for the stimulation, inhibition, or modulation of lymphangiogenesis and lymphatic function in lymphedematous tissues or tumors of adult animals (17), there remains a crucial need to identify additional genetic and ph…”
BackgroundCaron, K. M., & Smithies, O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.615 · Cited by 346 · cited 5×
“(B) To determine whether LECs express AM during development, we used an EGFP that serves as a biological marker of AM gene expression in AM gene–targeted mice (35).”
BackgroundMethodSelf-citationPolycystin 1 is required for the structural integrity of blood vessels
Kim, K., Drummond, I., Ibraghimov-Beskrovnaya, O., Klinger, K., & Arnaout, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040550097 · Cited by 338
Filamin A (FLNA) is required for cell–cell contact in vascular development and cardiac morphogenesis
Feng, Y., Chen, M. H., Moskowitz, I. P., Mendonza, A. M., Vidali, L., Nakamura, F., Kwiatkowski, D. J., & Walsh, C. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609628104 · Cited by 323
Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis
Cao, Y. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1693 · Cited by 307 · cited 2×
“Recent studies have also brought the lymphatic system to the forefront as an important route of tumor metastasis (3, 6), the major cause for treatment failure and decreased survival in cancer patients.”
BackgroundBraren, R., Hu, H., Kim, Y. H., Beggs, H. E., Reichardt, L. F., & Wang, R. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200506184 · Cited by 246
Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology
Witte, M. H., Bernas, M. J., Martin, C. P., & Witte, C. L. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1163 · Cited by 238 · cited 1×
“Failure or insufficient function of the lymphatic vascular system results in disfiguring, disabling, and sometimes life-threatening swelling of the limbs, called lymphedema (57), which most often occurs as a result of a parasitic filarial infection or secondary to surgical removal of lymph nodes, radiation therapy, or…”
BackgroundTHE LYMPHATIC VASCULATURE: Recent Progress and Paradigms
Oliver, G., & Alitalo, K. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.012704.132338 · Cited by 237 · cited 1×
“Despite its central roles in both normal and disease physiology, our understanding of the development and molecular regulation of the lymphatic vascular system lags far behind that of the parallel blood vascular system (6, 7).”
BackgroundAngiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation
Morisada, T., Oike, Y., Yamada, Y., Urano, T., Akao, M., Kubota, Y., Maekawa, H., Kimura, Y., Ohmura, M., Miyamoto, T., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3382 · Cited by 235 · cited 15×
“Consistently, we found that RAMP2–/– LECs appeared markedly thinner than wild-type LECs.”
BackgroundInfluentialAdrenomedullin as an Autocrine/Paracrine Apoptosis Survival Factor for Rat Endothelial Cells
Kato, H. (1997) · Endocrinology · doi:10.1210/en.138.6.2615 · Cited by 228
Lymphatic endothelium: a new frontier of metastasis research
Karkkainen, M. J., Mäkinen, T., & Alitalo, K. (2002) · Nature Cell Biology · doi:10.1038/ncb0102-e2 · Cited by 226 · cited 1×
“Recent studies have also brought the lymphatic system to the forefront as an important route of tumor metastasis (3, 6), the major cause for treatment failure and decreased survival in cancer patients.”
BackgroundInflammatory Manifestations of Experimental Lymphatic Insufficiency
Tabibiazar, R., Cheung, L., Han, J., Swanson, J., Beilhack, A., An, A., Dadras, S. S., Rockson, N., Joshi, S., Wagner, R., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030254 · Cited by 222 · cited 1×
“Several comparative transcriptional profiling studies have shown enhanced expression of AM signaling genes in lymphatic versus blood endothelial cells (46, 47) and lymphedematous versus normal vasculature (48).”
BackgroundAdrenomedullin Reduces Endothelial Hyperpermeability
Hippenstiel, S., Witzenrath, M., Schmeck, B., Hocke, A., Krisp, M., Krüll, M., Seybold, J., Seeger, W., Rascher, W., Schütte, H., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000036603.61868.f9 · Cited by 191 · cited 1×
“Despite the well-established role for AM in maintaining vascular permeability (38, 39), we very rarely observed blood hemorrhage, and only occasionally in embryos that were visibly deteriorated or near death.”
BackgroundCalcitonin gene-related peptide and its role in migraine pathophysiology
Arulmani, U., MaassenVanDenBrink, A., Villalón, C. M., & Saxena, P. R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.035 · Cited by 176 · cited 1×
“Since the AM receptor and the 3 mammalian RAMPs are highly expressed in the vasculature, this paradigm of cell signaling is being explored pharmaceutically for the potential treatment of conditions such as migraine (30), pulmonary hypertension (31), and other cardiovascular disorders (32), and for the modulation of ca…”
BackgroundMolecular lymphangiogenesis: new players
Tammela, T., Petrova, T. V., & Alitalo, K. K. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.06.004 · Cited by 163 · cited 1×
“While a few of these gene products, such as VEGFC and angiopoietins, show promise as potential targets for the stimulation, inhibition, or modulation of lymphangiogenesis and lymphatic function in lymphedematous tissues or tumors of adult animals (17), there remains a crucial need to identify additional genetic and ph…”
BackgroundZudaire, E., Martı́nez, A., & Cuttitta, F. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00037-5 · Cited by 162 · cited 1×
“Adrenomedullin (AM) is a multifunctional, 52-aa peptide vasodilator that is pathologically elevated in a variety of tumors (19) and cardiovascular conditions (20).”
BackgroundFernandez-Sauze, S., Delfino, C., Mabrouk, K., Dussert, C., Chinot, O. L., Martin, P., Grisoli, F., Ouafik, L., & Boudouresque, F. (2004) · International Journal of Cancer · doi:10.1002/ijc.11663 · Cited by 153
Dackor, R. T., Fritz-Six, K., Dunworth, W. P., Gibbons, C. L., Smithies, O., & Caron, K. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2511-2518.2006 · Cited by 146 · cited 5×
“The targeting vector was designed so that loxP sites would flank the same exons that were deleted in the calcrl global knockout (36).”
BackgroundMethodSelf-citationProx1, master regulator of the lymphatic vasculature phenotype
Hong, Y., & Detmar, M. J. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0747-8 · Cited by 143 · cited 1×
“One of the earliest molecular markers distinguishing venous endothelial cells with a lymphatic bias is the transcription factor prospero-related homeobox 1 (Prox1) (8).”
BackgroundHay, D. L., Howitt, S. G., Conner, A. C., Schindler, M., Smith, D. M., & Poyner, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705472 · Cited by 132 · cited 2×
“Inhibition of AM-mediated ERK phosphorylation by a RAMP2-specific AM inhibitor, AM22–52 (45), and by the MAPK inhibitor PD98057 confirmed that ERK activation by AM signaling in HMVEC-dLys is mediated through a RAMP2CLR receptor complex (Figure 8E).”
BackgroundTaniguchi, K., Kohno, R.-I., Ayada, T., Kato, R., Ichiyama, K., Morisada, T., Oike, Y., Yonemitsu, Y., Maehara, Y., & Yoshimura, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01600-06 · Cited by 132 · cited 1×
“showed that mice with double genetic deletion of Spred-1 and -2 develop marked edema and dilated, blood-filled lymphatic vessels (56).”
BackgroundKim, W., Moon, S.-O., Sung, M. J., Kim, S. H., Lee, S., So, J.-N., & Park, S. K. (2003) · The FASEB Journal · doi:10.1096/fj.02-1209fje · Cited by 132
Yurugi-Kobayashi, T., Itoh, H., Schroeder, T., Nakano, A., Narazaki, G., Kita, F., Yanagi, K., Hiraoka‐Kanie, M., Inoue, E., Ara, T., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000234978.10658.41 · Cited by 132 · cited 1×
“Similar results have been recapitulated in vivo through the use of a hind-limb ischemia model (27) and a differentiated ES cell culture model (28) in which AM treatment promotes an angiogenic response.”
ResultSebzda, E., Hibbard, C., Sweeney, S. M., Abtahian, F., Bezman, N., Clemens, R. A., Maltzman, J. S., Cheng, L., Liu, F., Turner, M., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.07.007 · Cited by 125 · cited 1×
“However, the Tie2Cre transgene is also expressed in cells of the hematopoietic lineage, which have modest expression of AM signaling components (53, 54) and have been previously demonstrated to contribute to lymphatic vascular development (55).”
BackgroundAngiogenic Effects of Adrenomedullin in Ischemia and Tumor Growth
Iimuro, S., Shindo, T., Moriyama, N., Amaki, T., Niu, P., Takeda, N., Iwata, H., Zhang, Y., Ebihara, A., & Nagai, R. (2004) · Circulation Research · doi:10.1161/01.res.0000138018.61065.d1 · Cited by 123 · cited 1×
“Similar results have been recapitulated in vivo through the use of a hind-limb ischemia model (27) and a differentiated ES cell culture model (28) in which AM treatment promotes an angiogenic response.”
ResultPathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders
Ishimitsu, T., Ono, H., Minami, J., & Matsuoka, H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.004 · Cited by 119 · cited 1×
“Since the AM receptor and the 3 mammalian RAMPs are highly expressed in the vasculature, this paradigm of cell signaling is being explored pharmaceutically for the potential treatment of conditions such as migraine (30), pulmonary hypertension (31), and other cardiovascular disorders (32), and for the modulation of ca…”
BackgroundDackor, R., Fritz-Six, K., Smithies, O., & Caron, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703544200 · Cited by 114 · cited 2×
“However, our previous observations that RAMP3-null mice survive to adulthood with few phenotypic defects (34) demonstrates that RAMP3 is unable to fully replenish RAMP2-mediated AM signaling in vivo.”
BackgroundSelf-citationReceptor Activity-Modifying Proteins: RAMPing up Adrenomedullin Signaling
Gibbons, C., Dackor, R. T., Dunworth, W. P., Fritz-Six, K. L., & Caron, K. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0156 · Cited by 106 · cited 1×
“Adrenomedullin (AM) is a multifunctional, 52-aa peptide vasodilator that is pathologically elevated in a variety of tumors (19) and cardiovascular conditions (20).”
BackgroundSelf-citationAdrenomedullin: angiogenesis and gene therapy
Nagaya, N., Mori, H., Murakami, S., Kangawa, K., & Kitamura, S. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00662.2004 · Cited by 103 · cited 2×
“AM is a secreted peptide vasodilator that is highly expressed in blood endothelial cells and induced by hypoxia to promote angiogenesis and inhibit vascular permeability (31, 51).”
BackgroundLymphatic endothelial regulation, lymphoedema, and lymph node metastasis
Karkkainen, M. J., & Alitalo, K. K. (2002) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0286 · Cited by 90 · cited 1×
“Failure or insufficient function of the lymphatic vascular system results in disfiguring, disabling, and sometimes life-threatening swelling of the limbs, called lymphedema (57), which most often occurs as a result of a parasitic filarial infection or secondary to surgical removal of lymph nodes, radiation therapy, or…”
BackgroundCrosstalk between angiogenesis and lymphangiogenesis in tumor progression
Scavelli, C., Vacca, A., Pietro, G. D., Dammacco, F., & Ribatti, D. (2004) · Leukemia · doi:10.1038/sj.leu.2403355 · Cited by 87
Zwerts, F., Lupu, F., Vriese, A. D., Pollefeyt, S., Moons, L., Altura, R. A., Jiang, Y., Maxwell, P. H., Hill, P., Oh, H., et al. (2007) · Blood · doi:10.1182/blood-2006-06-028068 · Cited by 83
Adrenomedullin Promotes Proliferation and Migration of Cultured Endothelial Cells
MIYASHITA, K., ITOH, H., SAWADA, N., FUKUNAGA, Y., SONE, M., YAMAHARA, K., YURUGI, T., & NAKAO, K. (2003) · Hypertension Research · doi:10.1291/hypres.26.s93 · Cited by 81
The role of adrenomedullin in angiogenesis
Ribatti, D., Nico, B., Spinazzi, R., Vacca, A., & Nussdorfer, G. G. (2005) · Peptides · doi:10.1016/j.peptides.2005.02.017 · Cited by 79 · cited 1×
“AM is a secreted peptide vasodilator that is highly expressed in blood endothelial cells and induced by hypoxia to promote angiogenesis and inhibit vascular permeability (31, 51).”
BackgroundMiyashita, K., Itoh, H., Sawada, N., Fukunaga, Y., Sone, M., Yamahara, K., Yurugi-Kobayashi, T., Park, K., & Nakao, K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00484-8 · Cited by 70
Shimoda, H., Bernas, M. J., Witte, M. H., Gale, N. W., Yancopoulos, G. D., & Kato, S. (2007) · Cell and Tissue Research · doi:10.1007/s00441-006-0360-8 · Cited by 69 · cited 1×
“Finally, several genes have been implicated in the later stages of lymphatic vessel patterning and postnatal maturation, including podoplanin (13), neuropillin2 (14), FoxC2 (15), and angiopoietin-2 (16).”
BackgroundZhou, M., Simms, H. H., & Wang, P. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133253.45591.5b · Cited by 65
Steffensen, K. R., Holter, E., Båvner, A., Nilsson, M., Pelto‐Huikko, M., Tomarev, S. I., & Treuter, E. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400147 · Cited by 62 · cited 1×
“plasmid pFlag, either empty or containing full-length hProx1 (59), a kind”
BackgroundDevelopment of CGRP antagonists for the treatment of migraine.
Doods, H. N. (2001) · PubMed · Cited by 44
Julián, M., Cacho, M., García, M. A., Martín‐Santamaría, S., de Pascual‐Teresa, B., Ramos, A., Martínez, A., & Cuttitta, F. F. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.10.016 · Cited by 43 · cited 1×
“Since the AM receptor and the 3 mammalian RAMPs are highly expressed in the vasculature, this paradigm of cell signaling is being explored pharmaceutically for the potential treatment of conditions such as migraine (30), pulmonary hypertension (31), and other cardiovascular disorders (32), and for the modulation of ca…”
BackgroundRegulation and function of the CGRP receptor complex in human granulopoiesis
Harzenetter, M. D., Keller, U. B., Beer, S., Riedl, C., Peschel, C., & Holzmann, B. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00772-5 · Cited by 34 · cited 1×
“However, the Tie2Cre transgene is also expressed in cells of the hematopoietic lineage, which have modest expression of AM signaling components (53, 54) and have been previously demonstrated to contribute to lymphatic vascular development (55).”
BackgroundKis, B., Snipes, J. A., Deli, M. A., Ábrahám, C. S., Yamashita, H., Ueta, Y., & Busija, D. W. (2003) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-7091-0651-8_115 · Cited by 24 · cited 1×
“Despite the well-established role for AM in maintaining vascular permeability (38, 39), we very rarely observed blood hemorrhage, and only occasionally in embryos that were visibly deteriorated or near death.”
BackgroundAdrenomedullin is expressed in cord blood hematopoietic cells and stimulates their clonal growth
Pup, L. D., Belloni, A., Carraro, G., Angeli, S. D., Parnigotto, P., & Nussdorfer, G. G. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.2.157 · Cited by 13 · cited 1×
“However, the Tie2Cre transgene is also expressed in cells of the hematopoietic lineage, which have modest expression of AM signaling components (53, 54) and have been previously demonstrated to contribute to lymphatic vascular development (55).”
Background
Research works printed but not linked: 3
- Kato, 1997, Endocrinology., 138, 2615, 10.1210/endo.138.6.5197 · doi:10.1210/endo.138.6.5197 · Paper page
- Doods, 2001, Curr. Opin. Investig. Drugs., 2, 1261
- Del Pup, 2003, Int J Mol Med, 11, 157
Cited by
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tammela, T., & Alitalo, K. (2010) · Cell · doi:10.1016/j.cell.2010.01.045 · Cited by 1,441
“Mice deficient in the vasodilator and diuretic peptide adrenomedullin (AM) or components of its receptor complex (calcitonin receptor-like receptor and receptor activity-modifying protein 2 [RAMP2]) develop edema and embryonic lethality at midgestation (Fritz-Six et al., 2008).”
BackgroundLymphatic vascular morphogenesis in development, physiology, and disease
Schulte-Merker, S., Sabine, A., & Petrova, T. V. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201012094 · Cited by 394
Lymphatic Vessel Network Structure and Physiology
Breslin, J. W., Yang, Y., Scallan, J. P., Sweat, R. S., Adderley, S. P., & Murfee, W. L. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c180015 · Cited by 341
Gaengel, K., Niaudet, C., Hagikura, K., Laviña, B., Muhl, L., Hofmann, J. J., Ebarasi, L., Nyström, S., Rymo, S., Chen, L. L., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.005 · Cited by 317
“5 as a result of vascular abnormalities (Fritz-Six et al., 2008; Ichikawa-Shindo et al., 2008).”
BackgroundThe Lymphatic System in Health and Disease
Cueni, L. N., & Detmar, M. (2008) · Lymphatic Research and Biology · doi:10.1089/lrb.2008.1008 · Cited by 288
“89 The Lymphatic System in Disease”
Metadata
- Authors
- Fritz-Six, K. L., Dunworth, W. P., Li, M., & Caron, K. M.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-02
- Volume
- 118
- Issue
- 1
- Pages
- 40-50
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2147672
- OpenAlex
- W2013443224
- Semantic Scholar
- 240406e3bc090066339dd9f7bf51068c372b4377
- Cited by
- 261
- References
- 59
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 15 · 2023: 11 · 2022: 22 · 2021: 12 · 2020: 13 · 2019: 12 · 2018: 9 · 2017: 11 · 2016: 9 · 2015: 7 · 2014: 19 · 2013: 20 · 2012: 17
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Burroughs Wellcome Fund
- American Heart Association
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 046970, R01HD046970)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Health Sciences › Medicine › Surgery › Vascular Malformations and Hemangiomas
- Keywords
- adrenomedullin, lymphangiogenesis, calcitonin receptor-like receptor, RAMP2, embryonic lethality, lymphatic endothelial cell proliferation, ERK signaling, Prox1, lymphatic vessels, metastasis, lymphedema treatment
- MeSH terms
- Prospero-Related Homeobox 1 Protein, Animals, Female, Homeostasis, Lymphatic Diseases, Lymphedema, Male, Membrane Proteins, Neoplasm Metastasis, Neoplasms, Pregnancy, Receptors, Calcitonin, Homeodomain Proteins, Neovascularization, Physiologic, MAP Kinase Signaling System, Embryo Loss, Tumor Suppressor Proteins, Lymphatic Vessels, Endothelial Cells, Embryonic Development, Intracellular Signaling Peptides and Proteins, Cell Proliferation, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 2, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.